194 related articles for article (PubMed ID: 36198829)
1. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
Diabetologia; 2023 Jan; 66(1):3-22. PubMed ID: 36198829
[TBL] [Abstract][Full Text] [Related]
2. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
Diabetes Care; 2022 Dec; 45(12):3058-3074. PubMed ID: 36202061
[TBL] [Abstract][Full Text] [Related]
3. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
Diabetologia; 2020 Feb; 63(2):229-241. PubMed ID: 31802144
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
[TBL] [Abstract][Full Text] [Related]
5. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
[TBL] [Abstract][Full Text] [Related]
6. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
8. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
[TBL] [Abstract][Full Text] [Related]
9. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
10. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
Grunberger G; Sherr J; Allende M; Blevins T; Bode B; Handelsman Y; Hellman R; Lajara R; Roberts VL; Rodbard D; Stec C; Unger J
Endocr Pract; 2021 Jun; 27(6):505-537. PubMed ID: 34116789
[TBL] [Abstract][Full Text] [Related]
11. Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Petrie JR; Peters AL; Bergenstal RM; Holl RW; Fleming GA; Heinemann L
Diabetologia; 2017 Dec; 60(12):2319-2328. PubMed ID: 29067486
[TBL] [Abstract][Full Text] [Related]
12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
Grunberger G; Handelsman Y; Bloomgarden ZT; Fonseca VA; Garber AJ; Haas RA; Roberts VL; Umpierrez GE
Endocr Pract; 2018 Mar; 24(3):302-308. PubMed ID: 29547046
[TBL] [Abstract][Full Text] [Related]
13. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Petrie JR; Peters AL; Bergenstal RM; Holl RW; Fleming GA; Heinemann L
Diabetes Care; 2017 Dec; 40(12):1614-1621. PubMed ID: 29070577
[TBL] [Abstract][Full Text] [Related]
14. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
15. USA Vs Europe: Who Is Leading the Diabetes Tech Race?
Acosta GJ; Brown S; Zand AM; Kansara A; Sadhu A
Curr Diab Rep; 2019 Nov; 19(11):128. PubMed ID: 31734741
[TBL] [Abstract][Full Text] [Related]
16. Diabetes technologies in people with type 1 diabetes mellitus and disordered eating: A systematic review on continuous subcutaneous insulin infusion, continuous glucose monitoring and automated insulin delivery.
Priesterroth L; Grammes J; Clauter M; Kubiak T
Diabet Med; 2021 Jul; 38(7):e14581. PubMed ID: 33826771
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
18. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
19. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
